Vasculitis in childhood (Q78374018)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380373%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

title

Vasculitis in childhood (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380373%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380373%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

author name string

Ilona Szer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380373%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380373%20AND%20SRC:MED&resulttype=core&format=json

Rheumatic Diseases Clinics of North America

13 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380373%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380373%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380373%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

page(s)

625-654

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380373%20AND%20SRC:MED&resulttype=core&format=json

Do vasculitis categorization systems really matter?

13 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Nomenclature and classification of vasculitis: plus ça change, plus c'est la même chose

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Heavy and light chain composition of serum IgA and IgA rheumatoid factor in Henoch-Schönlein purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Vasculitis from the pediatric perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Magnetic resonance imaging for early detection of Takayasu arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Takayasu arteritis in children and young indians

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Kawasaki disease: A brief history.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Superantigens, conventional antigens and the etiology of Kawasaki syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Treatment of Kawasaki disease: corticosteroids revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Kawasaki Disease: A Maturational Defect in Immune Responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Kawasaki disease: who is at risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Kawasaki disease in older children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Effects of gamma-globulin on the cardiac sequelae of Kawasaki disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Kawasaki disease in infants less than one year of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Kawasaki Disease in the Older Child

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Cardiac sequelae of Kawasaki disease among recurrent cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Polyarteritis nodosa in childhood a clinical pathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

1 reference

7 January 2021

15-year-old boy with abdominal pain and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Cyclophosphamide Therapy of Severe Systemic Necrotizing Vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Clinical observation of 14 cases of childhood polyarteritis nodosa in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Henoch-Schönlein purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Anaphylactoid purpura in children (Schonlein-Henoch syndrome): review with a follow-up of the renal complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Gastrointestinal endoscopy in Henoch-Schönlein purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Acute testicular pain: Henoch-Sch??nlein purpura versus testicular torsion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Impairment of lung diffusion capacity in Schönlein-Henoch purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Antineutrophil cytoplasmic antibodies (ANCA) of IgA class correlate with disease activity in adult Henoch-Schönlein purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Autoimmunity to glomerular antigens in Henoch-Schoenlein nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Henoch-Schonlein syndrome in children: gastrointestinal manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Gastrointestinal and renal involvement in vasculitis: management strategies in Henoch-Schönlein purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Incidence of renal complications in Schönlein-Henoch purpura syndrome in dependence of an early administration of steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Corticosteroid therapy does not prevent nephritis in Henoch-Schönlein purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Early tubular proteinuria and the development of nephritis in Henoch-Schönlein purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

The effect of triple therapy on rapidly progressive type of Henoch-Schönlein nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Multiple combined therapy for severe Henoch-Schönlein nephritis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Wegener granulomatosis in children and young adults. A case study of ten patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Wegener Granulomatosis: An Analysis of 158 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Methotrexate treatment of Wegener granulomatosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Renal involvement in polyarteritis nodosa: evaluation of 26 Turkish children

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Disease assessment and management of the vasculitides

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

Sarcoidosis and systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900008-X

7 January 2021

10.1016/S0889-857X(02)00008-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12380373%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

1 reference